Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Wen Huang

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Nutrition Journal|January 23, 2015
Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patientsCheng-Jen Ma, Jin-Ming Wu, Hsiang-Lin Tsai, et al.
Journal of Minimal Access Surgery|February 28, 2018
Short- and long-term outcomes of laparoscopic-assisted surgery, mini-laparotomy and conventional laparotomy in patients with Stage I-III colorectal cancerChin-Fan Chen, Yi-Chieh Lin, Hsiang-Lin Tsai, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2020
Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST)Hsiang-Lin Tsai, Ching-Wen Huang, Yi-Wen Lin, et al.
Iscience|June 16, 2025
A combinatorial and computational Tandem approach towards a universal therapeutics against ACE2-mediated coronavirus infectionsChia Yin Lee, Ching-Wen Huang, Louis De Falco, et al.
Cells|February 15, 2022
Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive BiomarkersMing-Wei Su, Chung-Ke Chang, Chien-Wei Lin, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Metabolic Syndromes as Important Comorbidities in Patients of Inherited Retinal Degenerations: Experiences from the Nationwide Health Database and a Large Hospital-Based CohortGuann-Jye Chiou, Ding-Siang Huang, Fung-Rong Hu, et al.
Frontiers in Oncology|December 6, 2021
Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC TreatmentHong-Hwa Chen, Tao-Wei Ke, Ching-Wen Huang, et al.
Nutrients|July 14, 2023
Efficacy and Safety of a Parenteral Nutrition Program for Patients with <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching StudyYu-Tang Chang, Chou-Chen Chen, Shih-Ching Chang, et al.
American Journal of Cancer Research|January 13, 2025
Outcomes of upfront primary tumor resection in patients with synchronous <i>RAS</i> wild-type metastatic colorectal cancerPo-Jung Chen, Chou-Chen Chen, Shih-Ching Chang, et al.
American Journal of Cancer Research|August 15, 2025
Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with <i>RAS</i> wild-type metastatic colorectal cancer: a nationwide real-world studyChing-Wen Huang, Chou-Chen Chen, Shih-Ching Chang, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Nutrition Journal|January 23, 2015
Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patientsCheng-Jen Ma, Jin-Ming Wu, Hsiang-Lin Tsai, et al.
Journal of Minimal Access Surgery|February 28, 2018
Short- and long-term outcomes of laparoscopic-assisted surgery, mini-laparotomy and conventional laparotomy in patients with Stage I-III colorectal cancerChin-Fan Chen, Yi-Chieh Lin, Hsiang-Lin Tsai, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2020
Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST)Hsiang-Lin Tsai, Ching-Wen Huang, Yi-Wen Lin, et al.
Iscience|June 16, 2025
A combinatorial and computational Tandem approach towards a universal therapeutics against ACE2-mediated coronavirus infectionsChia Yin Lee, Ching-Wen Huang, Louis De Falco, et al.
Cells|February 15, 2022
Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive BiomarkersMing-Wei Su, Chung-Ke Chang, Chien-Wei Lin, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Metabolic Syndromes as Important Comorbidities in Patients of Inherited Retinal Degenerations: Experiences from the Nationwide Health Database and a Large Hospital-Based CohortGuann-Jye Chiou, Ding-Siang Huang, Fung-Rong Hu, et al.
Frontiers in Oncology|December 6, 2021
Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC TreatmentHong-Hwa Chen, Tao-Wei Ke, Ching-Wen Huang, et al.
Nutrients|July 14, 2023
Efficacy and Safety of a Parenteral Nutrition Program for Patients with <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching StudyYu-Tang Chang, Chou-Chen Chen, Shih-Ching Chang, et al.
American Journal of Cancer Research|January 13, 2025
Outcomes of upfront primary tumor resection in patients with synchronous <i>RAS</i> wild-type metastatic colorectal cancerPo-Jung Chen, Chou-Chen Chen, Shih-Ching Chang, et al.
American Journal of Cancer Research|August 15, 2025
Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with <i>RAS</i> wild-type metastatic colorectal cancer: a nationwide real-world studyChing-Wen Huang, Chou-Chen Chen, Shih-Ching Chang, et al.
Pageof 20